Cham, Switzerland, Springer (2015)
He L et al
Cruysberg JR, Wevers RA, van Engelen BG, Pinckers A, van Spreeken A, Tolboom JJ
Landscapes Health & Medical Sciences (AREA) Chemical & Material Sciences (AREA) Organic Chemistry (AREA) Life Sciences & Earth Sciences (AREA) General Health & Medical Sciences (AREA) Medicinal Chemistry (AREA) Proteomics, Peptides & Aminoacids (AREA) Genetics & Genomics (AREA) Molecular Biology (AREA) Biophysics (AREA) Biochemistry (AREA) Gastroenterology & Hepatology (AREA) Engineering & Computer Science (AREA) Bioinformatics & Cheminformatics (AREA) Veterinary Medicine (AREA) Pharmacology & Pharmacy (AREA) Animal Behavior & Ethology (AREA) Public Health (AREA) Neurology (AREA) Neurosurgery (AREA) Biomedical Technology (AREA) Immunology (AREA) Toxicology (AREA) Zoology (AREA) Epidemiology (AREA) Chemical Kinetics & Catalysis (AREA) Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA) General Chemical & Material Sciences (AREA) Psychology (AREA) Psychiatry (AREA) Hospice & Palliative Care (AREA) Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA) Peptides Or Proteins (AREA) Description HEPATOCYTE GROWTH FACTOR MIMICS AS THERAPEUTIC AGENTS DESCRIPTION BACKGROUND OF THE INVENTION Field of the Invention The invention generally relates to methods of using hepatocyte growth factor (HGF) mimics to treat dementia and Parkinson's disease
Dyspepsia, characterized by upper abdominal discomfort, early satiety, or postprandial fullness, may affect a similar proportion of patients and can contribute to reduced caloric intake and weight loss, though it may also impact quality of life if severe or persistent
